Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Otorhinolaryngology

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 40 articles: HTML format

Single Articles

September 2025
1. VERHOEVEN RHA, Kuijper SC, Slingerland M, Wijnhoven B, et al
   Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
   Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70168.
   PubMed     Abstract available
   
   
   
2. OSWAL K, Barman S, Kerr AR, Zaman M, et al
   Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India.
   Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70160.
   PubMed     Abstract available
   
   
   
3. AMURE MT, Madathil SA, Laprise C, Rousseau MC, et al
   Oral co-infection with multiple alpha-human papillomavirus and head and neck cancer risk.
   Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70124.
   PubMed     Abstract available
   
   
   
4. DENNIS CD, Cohen DJ, Debnath K, Schwartz N, et al
   24R,25(OH)(2)D(3) regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane-associated receptor complexes in ER+ and ER- cells.
   Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70141.
   PubMed     Abstract available
   
   
   August 2025
5. NASMAN A, Birgersson M, Nasman T, Jortso E, et al
   Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022.
   Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70087.
   PubMed     Abstract available
   
   
   
6. ZHANG LT, Wu XY, Zhang HY, Li EM, et al
   Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.
   Int J Cancer. 2025 Aug 11. doi: 10.1002/ijc.70080.
   PubMed     Abstract available
   
   
   July 2025
7. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
   Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis.
   Int J Cancer. 2025 Jul 30. doi: 10.1002/ijc.70033.
   PubMed     Abstract available
   
   
   
8. YAN D, Wang L, Huang L, Cheng K, et al
   Evaluating ChatGPT's recommendations for systematic treatment decisions in recurrent or metastatic head and neck squamous cell carcinoma: Perspectives from experts and junior doctors.
   Int J Cancer. 2025 Jul 19. doi: 10.1002/ijc.70001.
   PubMed     Abstract available
   
   
   
9. WANG J, Wang L, Wang T, Tang T, et al
   Eye-sparing treatment for sinonasal tumors invading the orbit in the era of personalized therapy.
   Int J Cancer. 2025;157:151-160.
   PubMed     Abstract available
   
   
   June 2025
10. SONG XY, Lin L, Yang Y, Hu HH, et al
    Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy.
    Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.35515.
    PubMed     Abstract available
    
    
    
11. MODESTO A, Gibert S, Delmas C, Tougeron D, et al
    Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.
    Int J Cancer. 2025 Jun 20. doi: 10.1002/ijc.70011.
    PubMed     Abstract available
    
    
    May 2025
12. LIN H, Ma J, Heng Y, Zhu X, et al
    CD8(+) T cells in patients with hypopharyngeal squamous cell carcinoma are susceptible to radiation-induced damage.
    Int J Cancer. 2025;156:2010-2023.
    PubMed     Abstract available
    
    
    
13. YAN L, Lin Y, Lin W, Hong J, et al
    Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node metastasis: An 11-year experience at a tertiary cancer center.
    Int J Cancer. 2025 May 7. doi: 10.1002/ijc.35470.
    PubMed     Abstract available
    
    
    March 2025
14. LAN K, Liu S, Li S, Sun X, et al
    Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching.
    Int J Cancer. 2025 Mar 29. doi: 10.1002/ijc.35408.
    PubMed     Abstract available
    
    
    
15. 
    Correction to "Chronotherapy in head and neck cancer: A systematic review and meta-analysis".
    Int J Cancer. 2025 Mar 7. doi: 10.1002/ijc.35396.
    PubMed    
    
    
    February 2025
16. HU Y, Lu T, Zhang H, Chen B, et al
    Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.
    Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35382.
    PubMed     Abstract available
    
    
    
17. WANG H, Fan T, Lu Y, Que L, et al
    Baseline audiometric assessment of newly diagnosed nasopharyngeal carcinoma patients: a multicentre cross-sectional study.
    Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35358.
    PubMed     Abstract available
    
    
    January 2025
18. XIAO Z, Chen W, Du Y, Zeng F, et al
    Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial.
    Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340.
    PubMed     Abstract available
    
    
    December 2024
19. WANG J, Li B, Zhang Y, Luo X, et al
    Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35261.
    PubMed     Abstract available
    
    
    
20. JHAWAR SR, Haring C, Pan X, Ma J, et al
    Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35291.
    PubMed     Abstract available
    
    
    November 2024
21. JIN ZY, Liu K, Wallar G, Zhou JY, et al
    Environmental tobacco smoking (ETS) and esophageal cancer: A population-based case-control study in Jiangsu Province, China.
    Int J Cancer. 2024 Nov 18. doi: 10.1002/ijc.35254.
    PubMed     Abstract available
    
    
    
22. ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al
    Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234.
    PubMed     Abstract available
    
    
    
23. RUTKOWSKI TW, Kurczyk A, Drosik-Rutowicz K, Kiprian D, et al
    Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35248.
    PubMed     Abstract available
    
    
    October 2024
24. 
    RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer.
    Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35230.
    PubMed     Abstract available
    
    
    
25. HSU WL, Tao J, Fu S, Yu KJ, et al
    Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
    Int J Cancer. 2024;155:1400-1408.
    PubMed     Abstract available
    
    
    September 2024
26. WANG W, Ye L, Li H, Chen W, et al
    A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions.
    Int J Cancer. 2024 Sep 14. doi: 10.1002/ijc.35153.
    PubMed     Abstract available
    
    
    
27. PIRES C, Marques IJ, Saramago A, Moura MM, et al
    Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways.
    Int J Cancer. 2024 Sep 9. doi: 10.1002/ijc.35159.
    PubMed     Abstract available
    
    
    August 2024
28. JANKE F, Stritzke F, Dvornikovich K, Franke H, et al
    Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
    Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152.
    PubMed     Abstract available
    
    
    
29. SHI X, Lu M, Li X, Li J, et al
    The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35147.
    PubMed     Abstract available
    
    
    
30. HUANG H, Zhao Y, Deng Y, Zhan Z, et al
    Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.
    Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139.
    PubMed     Abstract available
    
    
    July 2024
31. WENG Z, Mai Z, Yuan J, Liu Q, et al
    Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy.
    Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35118.
    PubMed     Abstract available
    
    
    
32. LAURITZEN BB, Gronlund MW, Jakobsen KK, Justesen MM, et al
    Epidemiological trends and survival of oropharyngeal cancer in a high HPV-prevalent area: A Danish population-based study from 2000 to 2020.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35099.
    PubMed     Abstract available
    
    
    June 2024
33. MA L, Wang TM, He YQ, Liao Y, et al
    Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2024 Jun 18. doi: 10.1002/ijc.35061.
    PubMed     Abstract available
    
    
    
34. SUN X, Lin X, Yao J, Tian T, et al
    Potential causal links of long-term exposure to PM(2.5) and its chemical components with the risk of nasopharyngeal carcinoma recurrence: A 10-year cohort study in South China.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35047.
    PubMed     Abstract available
    
    
    May 2024
35. GUO D, Jin J, Li D, He Y, et al
    Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35003.
    PubMed     Abstract available
    
    
    April 2024
36. VASILIADOU I, Grose D, Wilson C, Thapa A, et al
    The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963.
    PubMed     Abstract available
    
    
    
37. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    PubMed     Abstract available
    
    
    
38. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    PubMed     Abstract available
    
    
    
39. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    PubMed     Abstract available
    
    
    March 2024
40. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.